Get the Stockscreener App
2.17
3.98%
-0.09
After Hours:
2.02
-0.15
-6.91%
Universe Pharmaceuticals INC stock is currently priced at $2.17, with a 24-hour trading volume of 81,419.
It has seen a -3.98% decreased in the last 24 hours and a -13.20% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.36 pivot point. If it approaches the $2.16 support level, significant changes may occur.
Previous Close:
$2.26
Open:
$2.39
24h Volume:
81,419
Market Cap:
$7.91M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-0.7045
EPS:
-3.08
Net Cash Flow:
$1.08M
1W Performance:
-6.06%
1M Performance:
-13.20%
6M Performance:
+95.28%
1Y Performance:
+258.86%
1D Range:
$2.13
$2.45
52W Range:
$0.331
$3.00
Universe Pharmaceuticals INC Stock (UPC) Company Profile
Name
Universe Pharmaceuticals INC
Sector
Phone
86 79 6840 3309
Address
No. 265, Jingjiu Avenue, Jinggangshan Eco and Tech Dev Zn, Ji'An
Universe Pharmaceuticals INC Stock (UPC) Latest News
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Universe Pharmaceuticals INC Stock (UPC) Financials Data
Universe Pharmaceuticals INC (UPC) Revenue 2024
UPC reported a revenue (TTM) of $32.31 million for the quarter ending September 30, 2023, a -32.66% decline year-over-year.
Universe Pharmaceuticals INC (UPC) Net Income 2024
UPC net income (TTM) was -$6.16 million for the quarter ending September 30, 2023, a -154.44% decrease year-over-year.
Universe Pharmaceuticals INC (UPC) Cash Flow 2024
UPC recorded a free cash flow (TTM) of $1.08 million for the quarter ending September 30, 2023, a +106.90% increase year-over-year.
Universe Pharmaceuticals INC (UPC) Earnings per Share 2024
UPC earnings per share (TTM) was -$1.70 for the quarter ending September 30, 2023, a -147.49% decline year-over-year.
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the development, manufacturing, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
2.43%
3.29%
Cap:
|
Volume (24h):